Cynara SRL
2.8 FTECynara reported total assets of €1.22m at the end of the 2025 financial year (annual accounts filed with the NBB on 29 Aug 2026), with 2.8 full-time equivalents.
The score of Cynara shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +40 % Total assets -2 % Headcount (avg FTE) 0 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Cynara's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 29 Aug 2026
- Year ended 31 Dec 2024filed on 30 Sep 2025
- Year ended 31 Dec 2023filed on 31 Aug 2024
- Year ended 31 Dec 2022filed on 03 Nov 2023
- Year ended 31 Dec 2021filed on 18 Oct 2022
Cynara's financial analysis
- Solvency34.1%sector median: 37.8%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Cynara
Cynara's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0862.412.845
- VAT number
- BE0862412845
- Peppol
- Registered · 0208:0862412845 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 29 Dec 2003
- Registered office
- 1000 Brussels
- Size
- Micro · 2.8 FTE
- Latest accounts
- 2025 · filed on 29 Aug 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Cynara (SRL) has been based in Brussels since 2003, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 40,184 € and equity of 413,946 €; its revenue is not published. With 2.8 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 34.1%, below the median of its sector (37.8%).
Companies similar to Cynara
Companies in the same business, of comparable size and area, outside its group.
- Apotheek DE Vlier Retail sale of pharmaceutical products Hasselt · balance sheet €1.22m
- Aa.Pharma Turnhout Retail sale of pharmaceutical products Turnhout · balance sheet €1.21m
- Apoteek DE FRE Retail sale of pharmaceutical products Haaltert · balance sheet €1.22m
- PHARMACIE Charleroi Nord Retail sale of pharmaceutical products Charleroi · balance sheet €1.22m
- Langenaken Retail sale of pharmaceutical products Bilzen-Hoeselt · balance sheet €1.22m
- Aclot Pharma Retail sale of pharmaceutical products Nivelles · balance sheet €1.22m
- Vandenabeele-Hungenaert Retail sale of pharmaceutical products Damme · balance sheet €1.23m
- Hulspharma Retail sale of pharmaceutical products Hulshout · balance sheet €1.20m
Frequently asked questions about Cynara
What is the revenue of Cynara?
Cynara files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Cynara?
In Belgium, the VAT number is the company number prefixed with BE: BE0862412845 for Cynara, if the company is VAT-registered. Its company number (CBE) is 0862.412.845.
Where is the registered office of Cynara?
According to the CBE register, the registered office of Cynara is in 1000 Brussels.
What is the equity of Cynara?
At the close of the 2025 financial year, the equity of Cynara amounts to 413,946 €, a solvency of 34.1% of total assets.
How many people work at Cynara?
2.8 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Cynara?
The register lists 2 active mandates at Cynara. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Cynara
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →